ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,475.09
      0.27%
      US Tech 100
      19,202.00
      -0.39%
      Dow Jones
      39,169.52
      0.13%
      Brent Oil
      86.73
      0.23%
      Bitcoin
      62,596.01
      -0.40%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Verastem Inc (VSTM)

      7. Verastem Inc (VSTM) News

      VSTM

      Verastem (VSTM)

      Verastem Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:VSTM
      DateTimeSourceHeadlineSymbolCompany
      07/27/20234:30PMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:VSTMVerastem Inc
      07/12/20238:50AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VSTMVerastem Inc
      07/11/20237:00AMBusiness WireVerastem Oncology Announces Promotion of Dan Paterson to Chief Executive OfficerNASDAQ:VSTMVerastem Inc
      07/10/20234:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VSTMVerastem Inc
      07/10/20234:05PMBusiness WireVerastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:VSTMVerastem Inc
      07/05/20234:05PMBusiness WireVerastem Oncology Announces Design for Confirmatory Trial of Avutometinib and Defactinib in Recurrent Low-Grade Serous Ovarian CancerNASDAQ:VSTMVerastem Inc
      06/28/20234:12PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VSTMVerastem Inc
      06/28/20234:11PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VSTMVerastem Inc
      06/23/20236:01AMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:VSTMVerastem Inc
      06/21/20234:25PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VSTMVerastem Inc
      06/21/20237:01AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VSTMVerastem Inc
      06/20/20234:22PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:VSTMVerastem Inc
      06/16/20235:00AMBusiness WireVerastem Oncology Announces Pricing of $85.0 Million Public Offering of Common Stock and Pre-Funded WarrantsNASDAQ:VSTMVerastem Inc
      06/15/20234:07PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:VSTMVerastem Inc
      06/15/20234:00PMBusiness WireVerastem Oncology Announces Proposed Public Offering of Common Stock and Pre-Funded WarrantsNASDAQ:VSTMVerastem Inc
      06/12/20234:38PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:VSTMVerastem Inc
      06/08/20235:25PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VSTMVerastem Inc
      05/31/20239:25AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VSTMVerastem Inc
      05/31/20239:11AMBusiness WireVerastem Oncology Announces Reverse Stock SplitNASDAQ:VSTMVerastem Inc
      05/25/20235:19PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VSTMVerastem Inc
      05/25/20235:05PMBusiness WireUpdated Data from Part A of Verastem Oncology's RAMP 201 Trial Show an Objective Response Rate of 45% in Patients with Recurrent Low-Grade Serous Ovarian Cancer Treated with Avutometinib and DefactinibNASDAQ:VSTMVerastem Inc
      05/16/20234:36PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VSTMVerastem Inc
      05/16/20234:36PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VSTMVerastem Inc
      05/16/20234:35PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VSTMVerastem Inc
      05/16/20234:35PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VSTMVerastem Inc
      05/16/20234:34PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VSTMVerastem Inc
      05/16/20234:32PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VSTMVerastem Inc
      05/16/20234:31PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:VSTMVerastem Inc
      05/16/20237:27AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VSTMVerastem Inc
      05/16/20237:00AMBusiness WireVerastem Oncology Appoints Karin Tollefson, PhD, to Board of DirectorsNASDAQ:VSTMVerastem Inc
       Showing the most relevant articles for your search:NASDAQ:VSTM